Cathie Wood’s ARK Invest Capitalizes on Archer Aviation Dip Amid Biotech Accumulation
Cathie Wood's ARK Invest executed strategic portfolio adjustments on November 6, seizing a 9.7% post-earnings drop in Archer Aviation (ACHR) to acquire 3 million shares worth $28.8 million. The eVTOL startup reported a $129.9 million Q3 loss as R&D spending for its Midnight air taxi project surged to $120.7 million.
ARK continued its biotech offensive, adding $2.84 million of BEAM Therapeutics (BEAM) and $2.63 million in 10x Genomics (TXG). The moves highlight Wood's signature contrarian strategy—backing high-growth, pre-revenue companies during temporary setbacks while doubling down on genomic innovation.